174 related articles for article (PubMed ID: 16764319)
1. [Incidence and risk factors of intraocular pressure elevation after triamcinolone acetonide administration for macular disorders].
Ito T; Nozaki M; Ogura Y
Nippon Ganka Gakkai Zasshi; 2006 May; 110(5):379-83. PubMed ID: 16764319
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
3. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
5. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
Liu X; Li Y; Zhang Y; Du W; Sun S; Lin B; Chen H; Cheng L
Retina; 2012 Oct; 32(9):1838-43. PubMed ID: 22487579
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
Jea SY; Byon IS; Oum BS
Korean J Ophthalmol; 2006 Jun; 20(2):99-103. PubMed ID: 16892645
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Aref AA; Scott IU; Oden NL; Ip MS; Blodi BA; VanVeldhuisen PC;
JAMA Ophthalmol; 2015 Sep; 133(9):1022-9. PubMed ID: 26086920
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
[TBL] [Abstract][Full Text] [Related]
13. The effect of intravitreal triamcinolone on intraocular pressure.
Kramar M; Vu L; Whitson JT; He YG
Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Degenring R
Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
[TBL] [Abstract][Full Text] [Related]
15. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Kawamura R; Inoue M; Shinoda H; Shinoda K; Itoh Y; Ishida S; Tsubota K
J Ocul Pharmacol Ther; 2011 Jun; 27(3):299-304. PubMed ID: 21510808
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
[TBL] [Abstract][Full Text] [Related]
17. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Yang YH; Hsu WC; Hsieh YT
Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
[TBL] [Abstract][Full Text] [Related]
18. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
20. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Chew EY; Glassman AR; Beck RW; Bressler NM; Fish GE; Ferris FL; Kinyoun JL;
Retina; 2011 Feb; 31(2):284-9. PubMed ID: 20948459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]